Benign multiple sclerosis in Crete

Multiple Sclerosis

Volumn 16, Issue 6, 2010, Pages 701-706

  Mastorodemos, V ^a   Nikolakaki, H ^b   Tzagournissakis, M ^a   Kotzamani, D ^a   Panou, T ^a   Spanaki, C ^a   Klados, G ^c   Maris, T ^c,d   Kontolaimaki, E ^e   Psaroudaki, K ^e   Chlouverakis, G ^a   Georgakakis, G ^b   Plaitakis, A ^a  

^a UNIVERSITY OF CRETE   (Greece)

^b 2nd Neurology Department General Hospital   (Greece)

^c Venizelion General Hospital   (Greece)

^d GENERAL HOSPITAL   (Greece)

^e Department of Biostatistics School of Health Sciences University of Crete ^*

Author keywords

Benign; Multiple sclerosis; Natural history; Prognostic factors

Indexed keywords

ADULT; CLINICAL ASSESSMENT; CONFERENCE PAPER; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE DURATION; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; FEMALE; GREECE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PROGNOSIS; QUESTIONNAIRE; RATING SCALE; RELAPSE; DISABILITY; KAPLAN MEIER METHOD; MIDDLE AGED; RISK FACTOR;

ADULT; AGE OF ONSET; DISABILITY EVALUATION; DISEASE PROGRESSION; FEMALE; GREECE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PROGNOSIS; QUESTIONNAIRES; RISK FACTORS;

EID: 77953784705     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458510364631     Document Type: Conference Paper

References (22)

1. Confavreux C., Vukusic S. Natural history of multiple sclerosis: a unifying concept. Brain 2006 ; 129: 606-616. (Pubitemid 43278223)
2. Weinshenker BG, Bass B., Rice GPA, et al. The natural history of multiple sclerosis: a geographically based study. Predictive value of the early clinical course. Brain 1989 ; 112: 1419-1428. (Pubitemid 20024212)
3. Eriksson M., Andersen O., Runmarker B. Long-term follow-up of patients with clinically isolated syndromes, relapsing-remitting and secondary progressive multiple sclerosis. Mult Scler 2003 ; 9: 260-274.
4. Thompson AJ, Hutchinson M., Brazil J., Feighery C., Martin EA A clinical and laboratory study of benign multiple sclerosis. Q J Med 1985 ; 225: 69-80.
5. Hawkins SA, McDonnell GV Benign multiple sclerosis? Clinical course, long term follow up, and assessment of prognostic factors. J Neurol Neurosurg Psychiatry 1999 ; 67: 148-152.
6. Hirst C., Ingram G., Swingler R., Compston DA, Pickersgill T., Robertson NP Change in disability in patients with multiple sclerosis: a 20-year prospective population-based analysis. J Neurol Neurosurg Psychiatry 2008 ; 79: 1137-1143.
7. Costelloe L., Thompson A., Walsh C., Tubridy N., Hutchinson M. Long-term clinical relevance of criteria for designating multiple sclerosis as benign after 10 years of disease. J Neurol Neurosurg Psychiatry 2008 ; 79: 1245-1248.
8. Ramsaransing G., Maurits N., Zwanikken C., De Keyser J. Early prediction of a benign course of multiple sclerosis on clinical grounds: a systematic review. Mult Scler 2001 ; 7: 345-347.
9. Pittock SJ, McClelland RL, Mayr WT, et al. Clinical implications of benign multiple sclerosis: a 20-year population- based follow-up study. Ann Neurol 2004 ; 56: 303-306.
10. Sayao AL, Devonshire V., Tremlett H. Longitudinal follow-up of benign multiple sclerosis at 20 years. Neurology 2007 ; 68: 496-500.
11. Ramsaransing GS, De Keyser J. Predictive value of clinical characteristics for benign multiple sclerosis. Eur J Neurol 2007 ; 14: 885-889.
12. McDonald WI, Compston A., Edan G., et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 2001 ; 50: 121-127.
13. Polman CH, Reingold SC, Edan G., et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the Mc-Donald Criteria. Ann Neurol 2005 ; 58: 840-846.
14. Kotzamani D., Panou T., Mastorodemos V., et al. Community-Based Study of MS: Natural History and Prognostic Factors. Ann Neurol 2007 ; 62: S73.
15. Poser CM Onset symptoms of multiple sclerosis. J Neurol Neurosurg Psychiatry 1995 ; 58: 253-254.
16. Lublin FD, Reingold SC Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 1996 ; 46: 907-911.
17. Kremenchutzky M., Cottrell D., Rice G., et al. The natural history of multiple sclerosis: a geographically based study. Progressive-relapsing and relapsing-progressive multiple sclerosis: a re-evaluation. Brain 1999 ; 122: 1941-1949. (Pubitemid 29473865)
18. Kurtzke JF Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983 ; 33: 1444-1452.
19. Mastorodemos V., Nikolakaki H., Tzagournissakis M., et al. Rapidly increasing incidence of multiple sclerosis (MS) over the past 25 years renders Crete a high-risk geographic region. Neurology 2006 ; 66 (suppl 2). A228.
20. Panou T., Mylonaki M., Kotzamani D., Chlouverakis G., Mastorodemos V., Plaitakis A. Factors associated with a steep rise in the incidence of MS on Crete over the past 25 years. Neurology 2008 ; 70 (suppl 1). A192.
21. Scarmeas N., Stern Y., Tang MX, Mayeux R., Luchsinger JA Mediterranean diet and risk for Alzheimers disease. Ann Neurol 2006 ; 59: 912-921. (Pubitemid 43830923)
22. Martínez-González MA, de la Fuente-Arrillaga C., Nunez-Cordoba JM, et al. Adherence to Mediterranean diet and risk of developing diabetes: prospective cohort study. BMJ 2008 ; 336: 1348-1351.